During the past decade, Instituto Jalisciense de Investigacion Clinica S.A. de C.V. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V." #1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V." are "Asthma" (3 trials), "COVID-19" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Chronic Rhinosinusitis" (2 trials) and "Nasal Polyps" (2 trials). Many other conditions were trialed in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V." in a lesser frequency.

Most popular intervention types in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V." are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Lebrikizumab" (4 trials), "Omalizumab" (2 trials), "Astegolimab" (1 trials) and "Inhaled mannitol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V." are 11 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Jalisciense de Investigacion Clinica S.A. de C.V.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Instituto Jalisciense de Investigacion Clinica S.A. de C.V., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Jalisciense de Investigacion Clinica S.A. de C.V., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".